Partnership in the picture: providing comprehensive support with InfarAMA

At e&a consultants, we want to support our clients fully. Bringing medicine to market, however, involves more than market access. To help you cover all facets of your product journey, we partner with strong experts in the field. One such partner is InfarAMA, which specialises in regulatory affairs, product vigilance, and quality assurance. Johan Eykens sat down with InfarAMA’s managing directors, Marian Coquel and Kristl Vandenbussche, to discuss the partnership’s strengths.

Marian and Kristl, why did you decide to partner with e&a consultants? 

Kristl: There’s a close synergy between registration and medicine pricing. The medical info that comes to surface during the registration process can be important to the pricing and market positioning of medicine. Therefore, it is in the client's interest to involve a market access department or partner in that process. To completely service our clients, it was important to us to find a market access partner we could trust.

Marian: I’ve known Johan for over twenty years. We have always worked well together as colleagues and consultants. Our companies share the same philosophy. We both have a pragmatic, no-nonsense approach and prioritise customised service. That match made it easy to form a partnership.

What does the partnership look like? 

Kristl: If a new client wants to launch a product, we can handle regulatory affairs and help them contact e&a consultants, our preferred partner for market access. If the client agrees, we can collaborate closely on their project, which can speed up the process.

Marian: It also happens that one of our existing clients wants to change the packaging or dosage strength of a product, which can influence the pricing. In that case, we refer them to e&a consultants, which can offer support in that area.

Johan: Likewise, when clients come to us with questions about obtaining permits or other legal requirements, we bring them in touch with InfarAMA. By referring to each other in this way, we want to provide clients with total service for their short—and long-term projects.

How do you ensure smooth and strong collaboration?

Johan: Our collaboration is not just project-based; we also actively exchange knowledge. Our consultants have previously given market access training to InfarAMA’s employees as part of their onboarding.

Kristl: Knowledge exchange is crucial to our partnership. If I have any pricing-related questions, all I have to do is send Johan an email. By better understanding what e&a consultants does, we know when to refer clients to them and what information to share when collaborating on a project.

Marian: Knowing what quality the other offers allows you to fully trust each other and refer to them confidently. The client notices that trust.

Finally, what benefits does this partnership offer clients?

Johan: In short, clients needing support in market access and regulatory affairs can count on a very efficient partnership to manage their case. Because we understand each other’s expertise so well, we can easily exchange information or consult one another in case of questions, if the client agrees to that. This makes handling a case so much easier.

Kristl: Most importantly, unlike large international consultants, our partnership bundles focus and knowledge of procedures in the Benelux, allowing us to offer more customised service. That is our biggest asset.

Do you need support in bringing your medicine to market? Schedule a strategic meeting with e&a consultants and InfarAMA around the table for a fully covered plan of approach.